Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency.

Ansar M, Ranza E, Shetty M, Paracha SA, Azam M, Kern I, Iwaszkiewicz J, Farooq O, Pournaras CJ, Malcles A, Kecik M, Rivolta C, Muzaffar W, Qurban A, Ali L, Aggoun Y, Santoni FA, Makrythanasis P, Ahmed J, Qamar R, Sarwar MT, Henry LK, Antonarakis SE.

Hum Mol Genet. 2019 Dec 31. pii: ddz303. doi: 10.1093/hmg/ddz303. [Epub ahead of print]

PMID:
31903486
2.

Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.

Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M.

Cells. 2019 Sep 16;8(9). pii: E1091. doi: 10.3390/cells8091091.

3.

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.

Evrard SM, Taranchon-Clermont E, Rouquette I, Murray S, Dintner S, Nam-Apostolopoulos YC, Bellosillo B, Varela-Rodriguez M, Nadal E, Wiedorn KH, Melchior L, Andrew E, Jones M, Ridgway J, Frykman C, Lind L, Rot M, Kern I, Speel EJM, Roemen GMJM, Trincheri N, Freiberger SN, Rechsteiner M.

J Mol Diagn. 2019 Nov;21(6):1010-1024. doi: 10.1016/j.jmoldx.2019.06.010. Epub 2019 Aug 22.

4.

Lung Cancer in Slovenia.

Zwitter M, Čufer T, Vrankar M, Kern I, Štupnik T, Rozman A, Koprivnikar H, Zadnik V.

J Thorac Oncol. 2019 Aug;14(8):1327-1331. doi: 10.1016/j.jtho.2019.02.025. No abstract available.

PMID:
31345331
5.

Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps.

Soklic TK, Rijavec M, Silar M, Koren A, Kern I, Hocevar-Boltezar I, Korosec P.

Radiol Oncol. 2019 Jul 17;53(3):323-330. doi: 10.2478/raon-2019-0029.

6.

Baeyer-Villiger oxidation tuned to chemoselective conversion of non-activated [18 F]fluorobenzaldehydes to [18 F]fluorophenols.

Ermert J, Castillo Meleán J, Humpert S, Modemann D, Krupp D, Kern I, Kreft S, Coenen HH.

J Labelled Comp Radiopharm. 2019 Jun 30;62(8):380-392. doi: 10.1002/jlcr.3740.

PMID:
31026351
7.

Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.

Gencer B, Rigamonti F, Nanchen D, Vuilleumier N, Kern I, Aghlmandi S, Klingenberg R, Räber L, Auer R, Carballo D, Carballo S, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F.

Eur J Clin Invest. 2019 Jul;49(7):e13117. doi: 10.1111/eci.13117. Epub 2019 May 7.

PMID:
30937890
8.

CD3+CD4-CD8- mucosal T cells are associated with uncontrolled chronic rhinosinusitis with nasal polyps.

Soklic TK, Silar M, Rijavec M, Koren A, Kern I, Hocevar-Boltezar I, Korosec P.

J Allergy Clin Immunol. 2019 Mar;143(3):1235-1237.e5. doi: 10.1016/j.jaci.2018.10.045. Epub 2018 Nov 12. No abstract available.

PMID:
30439404
9.

In Reply.

Brcic L, Vlacic G, Quehenberger F, Kern I.

Arch Pathol Lab Med. 2018 Nov;142(11):1311-1312. doi: 10.5858/arpa.2018-0196-LE. No abstract available.

PMID:
30407857
10.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

11.

Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.

Ryska A, Buiga R, Fakirova A, Kern I, Olszewski W, Plank L, Seiwerth S, Toth E, Zivka E, Thallinger C, Zielinski C, Brcic L.

Oncologist. 2018 Dec;23(12):e152-e158. doi: 10.1634/theoncologist.2018-0008. Epub 2018 Aug 3.

12.

Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders.

Allali G, Kern I, Laidet M, Armand S, Assal F.

J Alzheimers Dis. 2018;63(4):1373-1381. doi: 10.3233/JAD-171055.

PMID:
29843235
13.

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe.

Keppens C, Palma JF, Das PM, Scudder S, Wen W, Normanno N, van Krieken JH, Sacco A, Fenizia F, Gonzalez de Castro D, Hönigschnabl S, Kern I, Lopez-Rios F, Lozano MD, Marchetti A, Halfon P, Schuuring E, Setinek U, Sorensen B, Taniere P, Tiemann M, Vosmikova H, Dequeker EMC.

J Mol Diagn. 2018 Jul;20(4):483-494. doi: 10.1016/j.jmoldx.2018.03.006. Epub 2018 Apr 26.

14.

Corrigendum to "Systemic and airway oxidative stress in competitive swimmers" [Respiratory Medicine 137 (2018) 129-133].

Škrgat S, Korošec P, Kern I, Šilar M, Šelb J, Fležar M, Marčun R.

Respir Med. 2018 Sep;142:102. doi: 10.1016/j.rmed.2018.03.026. Epub 2018 Apr 3. No abstract available.

PMID:
29625797
15.

Systemic and airway oxidative stress in competitive swimmers.

Škrgat S, Korošec P, Kern I, Šilar M, Šelb J, Fležar M, Marčun R.

Respir Med. 2018 Apr;137:129-133. doi: 10.1016/j.rmed.2018.03.005. Epub 2018 Mar 3. Erratum in: Respir Med. 2018 Apr 3;:.

PMID:
29605195
16.

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.

Pasello G, Zago G, Lunardi F, Urso L, Kern I, Vlacic G, Grosso F, Mencoboni M, Ceresoli GL, Schiavon M, Pezzuto F, Pavan A, Vuljan SE, Del Bianco P, Conte P, Rea F, Calabrese F.

Ann Oncol. 2018 May 1;29(5):1258-1265. doi: 10.1093/annonc/mdy086.

PMID:
29514216
17.

Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.

Brcic L, Vlacic G, Quehenberger F, Kern I.

Arch Pathol Lab Med. 2018 Jun;142(6):747-752. doi: 10.5858/arpa.2017-0295-OA. Epub 2018 Mar 6.

PMID:
29509030
18.

PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.

Vrankar M, Zwitter M, Kern I, Stanic K.

Neoplasma. 2018;65(1):140-146. doi: 10.4149/neo_2018_170206N77.

PMID:
29322798
19.

Congenital Neuronal Ceroid Lipofuscinosis with a Novel CTSD Gene Mutation: A Rare Cause of Neonatal-Onset Neurodegenerative Disorder.

Varvagiannis K, Hanquinet S, Billieux MH, De Luca R, Rimensberger P, Lidgren M, Guipponi M, Makrythanasis P, Blouin JL, Antonarakis SE, Steinfeld R, Kern I, Poretti A, Fluss J, Fokstuen S.

Neuropediatrics. 2018 Apr;49(2):150-153. doi: 10.1055/s-0037-1613681. Epub 2017 Dec 28.

PMID:
29284168
20.

PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung.

Janzic U, Kern I, Janzic A, Cavka L, Cufer T.

Radiol Oncol. 2017 Sep 14;51(3):357-362. doi: 10.1515/raon-2017-0037. eCollection 2017 Sep.

21.

Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival.

Humar M, Kern I, Vlacic G, Hadzic V, Cufer T.

Radiol Oncol. 2017 Apr 26;51(2):195-202. doi: 10.1515/raon-2017-0020. eCollection 2017 Jun.

22.

[Raising the internist's know-how in the field of rare diseases: mitochondrial diseases as an illustrative example].

Tran C, Serratrice J, Nuoffer JM, Schaller A, Favrat B, Barbey F, Lobrinus JA, Kern I, Kuntzer T, Ballhausen D.

Rev Med Suisse. 2017 Jan 18;13(546):159-163. Review. French.

23.

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y.

Arch Pathol Lab Med. 2018 Mar;142(3):408-419. doi: 10.5858/arpa.2017-0106-SA. Epub 2017 Jul 7.

PMID:
28686497
24.

SERPINI1 pathogenic variants: An emerging cause of childhood-onset progressive myoclonic epilepsy.

Ranza E, Garcia-Tarodo S, Varvagiannis K, Guipponi M, Lobrinus JA, Bottani A, Kern I, Kurian M, Pittet MP, Antonarakis SE, Fluss J, Korff CM.

Am J Med Genet A. 2017 Sep;173(9):2456-2460. doi: 10.1002/ajmg.a.38317. Epub 2017 Jun 20.

PMID:
28631894
25.

High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients.

Koren A, Rijavec M, Sodja E, Kern I, Sadikov A, Kovac V, Korosec P, Cufer T.

Oncotarget. 2017 Apr 11;8(15):25384-25394. doi: 10.18632/oncotarget.15914.

26.

Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.

Hitij NT, Kern I, Sadikov A, Knez L, Stanič K, Zwitter M, Cufer T.

Clin Lung Cancer. 2017 May;18(3):e187-e196. doi: 10.1016/j.cllc.2016.11.021. Epub 2016 Dec 2.

PMID:
28089159
27.

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.

Brcic L, Jakopovic M, Misic M, Seiwerth F, Kern I, Smojver-Jezek S, Quehenberger F, Samarzija M, Seiwerth S.

Diagn Pathol. 2016 Sep 21;11(1):90.

28.

Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.

Zwitter M, Rajer M, Stanic K, Vrankar M, Doma A, Cuderman A, Grmek M, Kern I, Kovac V.

Cancer Biol Ther. 2016 Aug 2;17(8):833-9. doi: 10.1080/15384047.2016.1195049. Epub 2016 Jun 3.

29.

Bacteraemia before, during and after tooth extraction in horses in the absence of antimicrobial administration.

Kern I, Bartmann CP, Verspohl J, Rohde J, Bienert-Zeit A.

Equine Vet J. 2017 Mar;49(2):178-182. doi: 10.1111/evj.12581. Epub 2016 Jun 4.

PMID:
27062656
30.

Acute cortical deafness in a child with MELAS syndrome.

Pittet MP, Idan RB, Kern I, Guinand N, Van HC, Toso S, Fluss J.

J Inherit Metab Dis. 2016 May;39(3):465-466. doi: 10.1007/s10545-016-9929-x. Epub 2016 Apr 7.

31.

Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay.

Colaianna M, Ilmjärv S, Peterson H, Kern I, Julien S, Baquié M, Pallocca G, Bosgra S, Sachinidis A, Hengstler JG, Leist M, Krause KH.

Arch Toxicol. 2017 Jan;91(1):365-391. doi: 10.1007/s00204-016-1690-2. Epub 2016 Mar 25.

32.

BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.

Koren A, Rijavec M, Kern I, Sodja E, Korosec P, Cufer T.

Stem Cells Int. 2016;2016:9714315. doi: 10.1155/2016/9714315. Epub 2015 Dec 7.

33.

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B.

J Pathol. 2015 Oct;237(2):203-14. doi: 10.1002/path.4567. Epub 2015 Jul 14.

PMID:
26011651
34.

[Inborn errors of metabolism: transition from childhood to adulthood].

Tran C, Barbey F, Pitteloud N, Philippe J, Kern I, Bonafé L.

Rev Med Suisse. 2015 Feb 18;11(462):445-9. French.

PMID:
25915985
35.

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.

Ghanim B, Klikovits T, Hoda MA, Lang G, Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M, Filipits M, Scheed A, Jakopovic M, Samarzija M, Brcic L, Stancic-Rokotov D, Kern I, Rozman A, Dekan G, Klepetko W, Berger W, Glasz T, Dome B, Hegedus B.

Br J Cancer. 2015 Mar 3;112(5):783-92. doi: 10.1038/bjc.2015.9. Epub 2015 Jan 29.

36.

Feasibility and safety of parietal pleural cryobiopsy during semi-rigid thoracoscopy.

Rozman A, Camlek L, Marc Malovrh M, Kern I, Schönfeld N.

Clin Respir J. 2016 Sep;10(5):574-8. doi: 10.1111/crj.12256. Epub 2015 Jan 15.

PMID:
25516173
37.

Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations.

Zwitter M, Stanic K, Rajer M, Kern I, Vrankar M, Edelbaher N, Kovac V.

Radiol Oncol. 2014 Nov 5;48(4):361-8. doi: 10.2478/raon-2014-0038. eCollection 2014 Dec.

38.

Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy.

Huemer M, Scholl-Bürgi S, Hadaya K, Kern I, Beer R, Seppi K, Fowler B, Baumgartner MR, Karall D.

Orphanet J Rare Dis. 2014 Nov 15;9:161. doi: 10.1186/s13023-014-0161-1. Review.

39.

Let-7a is differentially expressed in bronchial biopsies of patients with severe asthma.

Rijavec M, Korošec P, Žavbi M, Kern I, Malovrh MM.

Sci Rep. 2014 Aug 18;4:6103. doi: 10.1038/srep06103.

40.

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.

Stanic K, Zwitter M, Hitij NT, Kern I, Sadikov A, Cufer T.

Radiol Oncol. 2014 Apr 25;48(2):173-83. doi: 10.2478/raon-2014-0016. eCollection 2014 Jun.

41.

Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies.

Rozman A, Camlek L, Kern I, Malovrh MM.

Radiol Oncol. 2014 Jan 22;48(1):67-71. doi: 10.2478/raon-2013-0068. eCollection 2014 Mar.

42.

Positive outcome following early diagnosis and treatment of pyridoxal-5'-phosphate oxidase deficiency: a case report.

Porri S, Fluss J, Plecko B, Paschke E, Korff CM, Kern I.

Neuropediatrics. 2014 Feb;45(1):64-8. doi: 10.1055/s-0033-1353489. Epub 2013 Sep 25.

PMID:
24297574
43.

Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.

Podgornik H, Sok M, Kern I, Marc J, Cerne D.

Pathol Res Pract. 2013 Aug;209(8):516-20. doi: 10.1016/j.prp.2013.06.004. Epub 2013 Jun 28.

PMID:
23880163
44.

Efficacy of tyrosine kinase inhibitors in routine clinical practice: epidermal growth factor mutations and their implications.

Ovcaricek T, Cufer T, Kern I, Sodja E, Sadikov A.

J Cancer Res Ther. 2013 Apr-Jun;9(2):261-6. doi: 10.4103/0973-1482.113379.

45.

Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.

Keil S, Anjema K, van Spronsen FJ, Lambruschini N, Burlina A, Bélanger-Quintana A, Couce ML, Feillet F, Cerone R, Lotz-Havla AS, Muntau AC, Bosch AM, Meli CA, Billette de Villemeur T, Kern I, Riva E, Giovannini M, Damaj L, Leuzzi V, Blau N.

Pediatrics. 2013 Jun;131(6):e1881-8. doi: 10.1542/peds.2012-3291. Epub 2013 May 20.

PMID:
23690520
46.

Rigid versus semi-rigid thoracoscopy for the diagnosis of pleural disease: a randomized pilot study.

Rozman A, Camlek L, Marc-Malovrh M, Triller N, Kern I.

Respirology. 2013 May;18(4):704-10. doi: 10.1111/resp.12066.

PMID:
23418922
47.

Is survivin expression prognostic or predictive in malignant pleural mesothelioma?

Hmeljak J, Erčulj N, Dolžan V, Pižem J, Kern I, Kovač V, Cemažar M, Cör A.

Virchows Arch. 2013 Mar;462(3):315-21. doi: 10.1007/s00428-013-1373-9. Epub 2013 Jan 29.

PMID:
23358691
48.

Vitamin D deficiency: a forgotten treatable cause of motor delay and proximal myopathy.

Fluss J, Kern I, de Coulon G, Gonzalez E, Chehade H.

Brain Dev. 2014 Jan;36(1):84-7. doi: 10.1016/j.braindev.2012.11.014. Epub 2012 Dec 27.

PMID:
23273989
49.

Embryonic stem cell-based screen for small molecules: cluster analysis reveals four response patterns in developing neural cells.

Kern I, Xu R, Julien S, Suter DM, Preynat-Seauve O, Baquié M, Poncet A, Combescure C, Stoppini L, Thriel CV, Krause KH.

Curr Med Chem. 2013;20(5):710-23.

PMID:
23231350
50.

Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy.

Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T.

Eur J Cancer. 2012 Dec;48(18):3378-85. doi: 10.1016/j.ejca.2012.06.011. Epub 2012 Jul 12.

PMID:
22795264

Supplemental Content

Support Center